scispace - formally typeset
C

Carlo Naldoni

Researcher at University of Turin

Publications -  102
Citations -  3698

Carlo Naldoni is an academic researcher from University of Turin. The author has contributed to research in topics: Breast cancer & Mass screening. The author has an hindex of 28, co-authored 100 publications receiving 3461 citations.

Papers
More filters
Journal ArticleDOI

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

TL;DR: HPV-based screening is more effective than cytology in preventing invasive cervical cancer, by detecting persistent high-grade lesions earlier and providing a longer low-risk period, but in younger women, HPV screening leads to over-diagnosis of regressive CIN2.
Journal ArticleDOI

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

TL;DR: The large relative sensitivity of HPV testing compared with conventional cytology and the difference between relative sensitivity during phases 1 and 2 suggests that there is frequent regression of CIN2+ that are detected by direct referral of younger HPV-positive women to colposcopy.
Journal ArticleDOI

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial

TL;DR: Liquid based cytology showed no statistically significant difference in sensitivity to conventional cytology for detection of cervical intraepithelial neoplasia of grade 2 or more, and more positive results were found, however, leading to a lower positive predictive value.